Article and Video CATEGORIES

Cancer Journey

Search By

ABOUT
Denise Brock

Denise has over 30 years of varying experience in the healthcare arena.  In August 2009 she joined The Global Resource for Advancing Cancer Education as one of its first employees.  She has grown with the organization and now oversees the operational movement of programs, efficiency, and effectiveness within the organization, as well as the daily processes and functions.  

 

Register Now for OncTalk 2021
Author
Denise Brock
OncTalk 2021
Register Now! 
OncTalk 2021, a FREE Online Patient Education EventClick Here to Register
December 11, 2021, 8AM Pacific Time, 11 AM Eastern Time 

Agenda           Faculty       **subject to change


 

Don't forget

2021 Targeted Therapies Patient Forum

English and Spanish 

available on-demand! 

Available on Demand

2021 Targeted Therapies Patient Forum

Click to Access ON Demand Event

           

Disponible bajo demanda

2021 Foro de Pacientes de Terapias Dirigidas

Click to view Event On Demand

Video Language

Next Previous link

Previous PostNext Post

Related Content

Article
The article describes the AVO treatment, a combination therapy for Chronic Lymphocytic Leukemia (CLL), particularly for high-risk patients. CLL is a slow-growing cancer where abnormal white blood cells accumulate. "High-risk" CLL refers to cases with specific genetic changes (e.g., in TP53) that make the disease harder to treat.
Image
2025 Spanish Targeted Therapy in Lung Cancer Patient Forum
Article
Da click aquí para más información y para registrarte ahora